Brief: Iterum Therapeutics Resubmits New Drug Application To U.S. FDA For Oral Sulopenem
29/04/2024 13:08
April 29 (Reuters) - Iterum Therapeutics PLC ITRM.O :
* ITERUM THERAPEUTICS RESUBMITS NEW DRUG APPLICATION TO U.S.
FOOD
AND DRUG ADMINISTRATION FOR ORAL SULOPENEM
* ITERUM THERAPEUTICS PLC: POTENTIAL APPROVAL EARLY Q4 2024
Source text for Eikon: ID:nGNXcbP0ln
Further company coverage: ITRM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Iterum Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Entergy, US natgas stocks, Brown-Forman, Datacentrex
U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services
Iterum Therapeutics plummets after filing wind up petition
Iterum seeks court-led dissolution amid cash crisis, inability to raise funds (updated)
Iterum files wind-up petition due to limited cash, inability to raise equity